Equifax (NYSE:EFX) Reaches New 12-Month Low Following Analyst Downgrade

Equifax, Inc. (NYSE:EFX) shares hit a new 52-week low during mid-day trading on Thursday after JPMorgan Chase & Co. lowered their price target on the stock from $260.00 to $230.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Equifax traded as low as $166.02 and last traded at $180.18, with a volume of 4896854 shares traded. The stock had previously closed at $175.05.

Several other research analysts also recently weighed in on EFX. BMO Capital Markets set a $195.00 target price on shares of Equifax in a research report on Thursday. UBS Group set a $230.00 target price on shares of Equifax in a research note on Thursday. Barclays reduced their target price on Equifax from $240.00 to $215.00 and set an “equal weight” rating for the company in a report on Thursday. Robert W. Baird set a $250.00 price target on Equifax in a report on Thursday. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Equifax in a research note on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Equifax presently has an average rating of “Moderate Buy” and an average price target of $240.33.

Key Stories Impacting Equifax

Here are the key news stories impacting Equifax this week:

• Positive Sentiment: Q4 beat and constructive guidance: Equifax reported a Q4 beat on revenue and EPS, and set FY2026 guidance (EPS 8.30–8.70) and Q1 guidance that signal continued top-line growth — a primary reason investors are bidding the stock up. Read More.
• Positive Sentiment: AI expansion and government segment momentum: Management highlighted AI-powered product expansion and a rebound in the government business, which supports longer-term revenue upside and premium valuation expectations. Read More.
• Positive Sentiment: VantageScore traction and partnerships: Execs noted VantageScore adoption gains and a new partnership (Gen + Equifax) to broaden consumer financial solutions — both support recurring data/licensing growth. Read More. | Read More.
• Neutral Sentiment: Analysts still bullish despite cuts: Several firms cut price targets after the quarter but maintained Buy/Overweight/Outperform ratings (JPM, RBC, Wells, Needham, Morgan Stanley), leaving meaningful upside in consensus PTs even after downgrades. These mixed signals can mute momentum but keep analyst support. Read More.
• Negative Sentiment: Regulatory/media scrutiny: A New York Times piece highlights senators accusing Equifax of “price‑gouging” on Medicaid services — elevated regulatory and political risk that could pressure valuation or lead to contract/price scrutiny in public-sector work. Read More.

Institutional Trading of Equifax

A number of institutional investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC increased its stake in shares of Equifax by 5.8% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,674 shares of the credit services provider’s stock worth $363,000 after purchasing an additional 92 shares during the last quarter. Lloyd Advisory Services LLC. bought a new stake in Equifax in the fourth quarter worth $95,000. MJP Associates Inc. ADV increased its position in Equifax by 14.0% during the fourth quarter. MJP Associates Inc. ADV now owns 1,611 shares of the credit services provider’s stock worth $350,000 after buying an additional 198 shares during the last quarter. IFP Advisors Inc raised its holdings in Equifax by 15.4% during the fourth quarter. IFP Advisors Inc now owns 628 shares of the credit services provider’s stock valued at $136,000 after buying an additional 84 shares in the last quarter. Finally, Cullen Frost Bankers Inc. acquired a new stake in shares of Equifax in the fourth quarter worth about $25,000. 96.20% of the stock is currently owned by institutional investors and hedge funds.

Equifax Stock Performance

The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.74 and a current ratio of 0.60. The company has a market cap of $23.93 billion, a P/E ratio of 36.75, a P/E/G ratio of 1.98 and a beta of 1.55. The firm has a 50 day moving average price of $212.79 and a 200-day moving average price of $227.58.

Equifax (NYSE:EFX) last issued its quarterly earnings data on Wednesday, February 4th. The credit services provider reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.05 by $0.04. The business had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.53 billion. Equifax had a return on equity of 19.27% and a net margin of 10.87%.The firm’s revenue was up 9.3% compared to the same quarter last year. During the same period last year, the business earned $2.12 EPS. Equifax has set its FY 2026 guidance at 8.300-8.700 EPS and its Q1 2026 guidance at 1.630-1.730 EPS. On average, research analysts predict that Equifax, Inc. will post 7.58 EPS for the current year.

About Equifax

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.